Antidepressant Use in Children and Teenagers

Topics: Antidepressants | Child Psychiatry | Depressive Disorder | Free Articles | Practice Tools and Tips | Psychopharmacology Tips

Should We Add Stimulants to SSRIs to Treat Geriatric Depression?

Topics: Depressive Disorder | Psychopharmacology Tips | Research Updates

Rexulti for Schizophrenia and MDD: Is It Abilify, Round 2?

Topics: Antidepressants | Depressive Disorder | News of Note

Neurostimulation Devices for Depression: An Overview

Topics: Brain Devices | Depressive Disorder | Practice Tools and Tips

When we last reviewed neurostimulation devices 3 years ago, we concluded that there was some promise—but more sizzle than beef. Now there are more devices and more data. But is there more beef? Maybe. We generally think of neurostimulation as a new technology, but its history is long. Beginning in the 1870s and through the turn of the last century,

Fisher Wallace and Alpha-Stim for Depression? Claims vs Evidence

Topics: Brain Devices | Depressive Disorder | Free Articles | Practice Tools and Tips

Carly Simon swears by it. The daytime show “The Doctors” gave it a glowing review. Ads for it seem to be invading psychiatrists’ Google search results. We’re talking, of course, about the Fisher Wallace Stimulator, touted by the manufacturer as being an effective treatment for depression, anxiety, insomnia, and pain (Fisher Wallace website). The

Which TMS Device Should You Buy?

Topics: Brain Devices | Depressive Disorder

So let’s say you’ve decided to take the TMS plunge. With three devices currently FDA cleared, you have some decisions to make. The following table brings together some information you might find useful. I focused on Neuronetics and Brainsway, with a blurb at the end about Magstim, the latest device to be approved. Material for this comparison came f

Reflections on the Past and Future of TMS

Topics: Brain Devices | Depressive Disorder

The Practice of Interventional Psychiatry

Topics: Brain Devices | Depressive Disorder

To Prevent Depression in Teens, Teach about Change

Topics: Child Psychiatry | Depressive Disorder | Research Updates

NSAIDs May be Effective for Depression

Topics: Depressive Disorder | Research Updates

Family Therapy for Serious Illness and Death

Topics: Depressive Disorder | Psychotherapy

Recognizing and Treating Complicated Grief

Topics: Depressive Disorder

It is widely recognized that the death of a loved one commonly triggers intense sorrow and emotional pain. However, scientists have long known that there is more to grief than just sadness. Bereaved individuals can experience a range of emotions, cognitions, and behaviors following loss. Typical grief reactions can range from short-term and mild to l

Does Dose Matter When it Comes to Antidepressants and Self-Harm?

Topics: Antidepressants | Child Psychiatry | Depressive Disorder

What’s the Benefit of Antidepressants for Young People?

Topics: Depressive Disorder | Research Updates

Connecting with a Group Can Help People with Depression

Topics: Depressive Disorder | News of Note

Chemical Imbalance’ Explanation Doesn’t Help Depressed Patients

Topics: Depressive Disorder | Research Updates

Has Research Found a Reliable Depression Biomarker in Boys?

Topics: Depressive Disorder | Research Updates

Is Treating Depression Good for the Heart?

Topics: Depressive Disorder | Research Updates

Fire in the Mind: The Depression-Inflammation Connection

Topics: Depressive Disorder

We have all bumped up against the limits of the current model of antidepressant treatments for depression: the patient who comes in with a laundry list of failed medication trials, or a number of other complaints depicting a portrait of malaise—aches, pains, anhedonia, fatigue, brain fog, digestive woes—that don’t really respond to currently avail

Does Brintellix Bring Anything New?

Topics: Antidepressants | Depressive Disorder

After a dry spell of new antidepressants—the last one to be approved was levomilnacipran (Fetzima), the active enantiomer of milnacipran (Savella) in July 2013—the FDA approved vortioxetine (Brintellix) in September. Vortioxetine is another serotonergic antidepressant. How exactly does it work, and what are its advantages over existing drugs? Vor